Lloyd Mitchell Segal
CIK 1477123 · PRESIDENT AND CEO · last filed 2026-01-12
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$430.5K
Companies
3
Total Filings
36
Lifetime Open-Market Net
-$1.89M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| AKTS | Director | 19,631 | $21.93 | $430.5K | $0 | 1 | 2026-01-12 |
| Repare Therapeutics Inc. (RPTX) Delisted | PRESIDENT AND CEO | 231,952 | $2.65 | $614.7K | -$1.89M | 17 | 2025-03-14 |
| Bausch Health Companies Inc. (BVF) Delisted | Director | — | — | — | $0 | 4 | 2010-07-07 |
Recent Filings · Page 3 of 4
36 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2013-06-03 | — | Disp (D) | −4,397 | -$399.3K | |
| 2013-05-28 | — | Grant (A) | +5,022 | $0 | |
| 2012-11-14 | — | Buy (P) | +240 | $13.0K | |
| 2012-11-14 | — | Buy (P) | +240 | $13.0K | |
| 2012-11-08 | — | Buy (P) | +745 | $40.6K | |
| 2012-07-03 | — | Grant (A) | +498 | $0 | |
| 2012-06-04 | — | Grant (A) | +8,062 | $0 | |
| 2012-04-03 | — | Grant (A) | +407 | $0 | |
| 2011-05-23 | — | Grant (A) | +4,397 | $0 | |
| 2011-03-08 | — | Grant (A) | — | $0 |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.